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Objective: This study was carried out to evaluate the long-term results of
mitral valve repair for mitral regurgitation caused by myxomatous disease
of the mitral valve and the late effects of chordal replacement with
expanded polytetrafluoroethylene sutures in this operation. Methods: A
total of 324 patients with mitral regurgitation caused by myxomatous
disease underwent mitral valve repair from 1981 to 1995; the group
comprised 241 men and 83 women whose mean age was 58 6 14 years.
Chordal replacement with expanded polytetrafluoroethylene sutures has
been performed in 165 patients since 1985. Most of the patients who had
chordal replacement with expanded polytetrafluoroethylene sutures had
prolapse of the anterior leaflet or prolapse of both leaflets, whereas most
patients who had mitral valve repair without chordal replacement had
prolapse of the posterior leaflet. Patients were followed up at annual
intervals and had a Doppler echocardiographic study. The follow-up was
complete and extended from 6 to 156 months (mean 36 6 30 months).
Results: Two operative and 21 late deaths occurred (14 cardiac and 7
noncardiac). At 10 years the actuarial survival was 75% 6 5%, the freedom
from stroke was 94% 6 2%, the freedom from transient ischemic attacks
was 92% 6 4%, the freedom from endocarditis was 99% 6 1%, the freedom
from mitral valve reoperation was 96% 6 1%, and the freedom from severe
mitral regurgitation was 93% 6 3%. Chordal replacement with expanded
polytetrafluoroethylene sutures had no effect on any of these end points.
Conclusions: Mitral valve repair was feasible in most patients with mitral
regurgitation caused by myxomatous disease and it was associated with low
rates of valve-related complications. Chordal replacement with expanded
polytetrafluoroethylene had no adverse effect on the late outcome and was
believed to have increased the probability of mitral valve repair. (J Thorac
Cardiovasc Surg 1998;115:1279-86)
Myxomatous disease of the mitral valve (MV) iscommon. It was found in 2.5% of men and
7.6% of women in a clinical epidemiologic study by
M-mode echocardiography.1 In most patients with
myxomatous MV disease, mitral regurgitation (MR)
of clinical importance never develops,1, 2 but be-
cause of the high prevalence of myxomatous disease
in North America, it is the most common cause of
MR that eventually necessitates surgical treatment.3
Although myxomatous disease of the MV is more
prevalent in women than in men by a ratio of
approximately 3:1, MR is more common in men
than in women by a ratio of almost 4:1.2, 4-6
MV repair has emerged as the procedure of
choice for patients with symptomatic MR resulting
from myxomatous disease because of its low opera-
tive mortality rate and beneficial effects in left
ventricular function when compared with mitral
valve replacement (MVR).7, 8 The results of MV
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repair have been so satisfactory that surgery is often
recommended for asymptomatic MR.9
The introduction of expanded polytetrafluoroeth-
ylene (ePTFE) sutures to replace chordae tendi-
neae10 increased the probability of MV repair in
patients with MR resulting from myxomatous dis-
ease of the MV.4, 11
This report is a study on the long-term results of
MV repair for MR resulting from myxomatous
disease of the MV. It also examines the late effects
of chordal replacement with ePTFE sutures during
MV repair.
Patients and methods
From 1981 to 1995, 417 patients with MR resulting
from myxomatous disease were operated on by one sur-
geon at The Toronto Hospital; 324 patients had MV
repair and 93 had MVR. Chordal replacement with
ePTFE was first used in July 1985. The proportion of
valves repaired increased from 30% in 1985 to approxi-
mately 90% by 1990 and thereafter. This increase in the
rate of valve repair was largely due to the use of chordal
replacement with ePTFE sutures.4
Table I shows the clinical data of all patients who had
MV repair, as well as of the subgroups who had repair
with and without chordal replacement with ePTFE su-
tures.
Table I. Clinical data of patients who had MV repair
All patients ePTFE No ePTFE p Value
No. of patients 324 165 159
Age (yr)
Mean 6 SD 58 6 14 56 6 14 61 6 12 0.003
Range 18 to 88 20 to 88 18 to 80
Sex
Male 241 (74) 130 (79) 111 (70)
Female 83 (26) 35 (21) 48 (30) 0.064
Heart rhythm
Sinus 214 (66) 110 (67) 107 (67)
Atrial fibrillation 107 (33) 54 (33) 50 (32) 0.826
Complete heart block 3 (1) 1 2 (1)
NYHA functional class
I 26 (8) 14 (8) 12 (8)
II 88 (27) 49 (30) 39 (24)
III 146 (45) 75 (45) 71 (45)
IV 64 (20) 27 (16) 37 (23) 0.415
Infective endocarditis
Active 5 (1.5) 2 (1) 3 (2)
Healed 28 (9) 20 (12) 8 (5) 0.07
Previous cardiac surgery
Mitral valve repair 5 (1.5) 4 (2) 1
Other 7 (2) 5 (3) 2 (1) 0.273
Left ventricular ejection fraction
.55% 125 (40) 65 (39) 64 (40)
41%-55% 170 (52) 85 (52) 85 (53)
21%-40% 23 (7) 13 (8) 10 (6)
,21% 2 (0.6) 2 (1) 0 0.515
MV disease
Leaflet prolapse 0.001
Anterior 58 (18) 49 (29) 9 (6)
Posterior 168 (52) 29 (17) 139 (87)
Anterior and posterior 98 (30) 87 (53) 11 (7) 0.001
Degree of myxomatous changes
Mild 175 (54) 66 (40) 109 (68)
Moderate 91 (28) 56 (34) 36 (23)
Advanced 57 (18) 43 (26) 14 (9)
Aortic valve disease 21 (6) 17 (10) 4 (2) 0.004
Tricuspid valve disease 9 (3) 6 (4) 3 (2) 0.338
Ascending aortic aneurysm 7 (2) 5 (3) 2 (1) 0.232
Coronary artery disease 40 (12) 16 (10) 24 (15) 0.140
Percentages are shown in parentheses. MV, Mitral valve; ePTFE, expanded polytetrafluoroethylene; SD, standard deviation; NYHA, New York Heart
Association.
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Operations were performed with the use of cardiopul-
monary bypass and mild systemic hypothermia. During
aortic crossclamping, myocardial protection was provided
by intermittent cold crystalloid cardioplegia until 1984 and
cold blood cardioplegia thereafter. Intraoperative Dopp-
ler echocardiography was routinely used after 1988. Pro-
lapse of the leaflets was determined during the operation
by carefully examining the level of the free margins of
every segment of the leaflets and comparing each level to
the level of a relatively normal one, for example, the
lateral commissural area of the posterior leaflet. The
degree of myxomatous changes in the leaflets was arbi-
trarily classified as mild if only the prolapsing segment
(e.g., the central scallop of the posterior leaflet) was
grossly involved by the myxomatous process, moderate if
both leaflets displayed some myxomatous changes, and
severe when both leaflets were myxomatous and contained
multiple aneurysms.
Prolapse of the posterior leaflet was managed by rect-
angular or quadrangular resection, but not more than one
third of the posterior leaflet was resected. If the prolapse
involved more than one third of the posterior leaflet, it
was corrected by chordal replacement with ePTFE su-
tures. Prolapse of the anterior leaflet was managed by
chordal shortening, chordal transfer, or chordal replace-
ment with ePTFE sutures. As we gained experience with
chordal replacement with ePTFE sutures, the first two
techniques were abandoned altogether.
The technique of chordal replacement with ePTFE
(Fig. 1) did not change during the study interval. We used
5-0 PTFE sutures* for prolapse of the anterior leaflet and
6-0 for the posterior leaflet and commissural areas. A 5-0
suture was passed two or three times through the fibrous
portion of the papillary muscle head and the ends were
tied together. Each arm of the suture was then passed
twice through the free margin of the leaflet, entering it
through the area where the native chorda was attached.
The two arms of the suture were no more than 4 or 5 mm
apart at the free margin of the leaflet. The length of the
ePTFE chordae was determined by comparison with the
opposing leaflet or by distending the left ventricle with
saline solution and observing where the free margins of
the leaflets should coapt. Once this was done, the two
ends were passed through the leaflet into its ventricular
surface and tied together. The number of new chordae
ranged from 2 to 16, mean of 6.6 per patient, assuming
that each PTFE suture corresponded to two new chordae.
Most patients also had a ring annuloplasty. Rigid and
flexible rings were used until 1991; since then only flexible
rings have been used. Patients with prosthetic mitral rings
were given warfarin sodium for anticoagulation during the
first 3 months if they were in sinus rhythm and perma-
nently if atrial fibrillation persisted. Table II summarizes
the operative procedures performed.
Patients were followed up by their referring cardiolo-
gists and our valve registry personnel. Postoperative
events were compiled and analyzed according to the
“Guidelines for Reporting Morbidity and Mortality After
Cardiac Valvular Operations.”12
Statistical analysis. Statistical analysis was per-
formed with the BMDP 1L program (BMDP Statistical
Software, Berkeley, Calif.). Discrete data were analyzed
by x2 or Fisher’s exact test where appropriate. Longi-
tudinal data were analyzed univariately by the product-
limit or Kaplan-Meier estimate. For these analyses,
time zero was normalized for all patients to the date of
operation, and the time to an event such as death,
thromboembolism, reoperation, or recurrent MR was
calculated as the event date minus the date of opera-
tion. Patients who did not have an event were censored
at the time of the last follow-up. Results of these
longitudinal data were expressed in percentages of the
means and the percentages of the standard errors of the
means. Clinical, hemodynamic, or operative variables
that were different by univariate analysis at p , 0.25
were entered into a Cox proportional hazard model to
determine the multivariate, independent predictors of
an event.
Results
There were two operative deaths. One young man
who had MV repair and aortic valve replacement
with a freehand aortic homograft had a cardiac
arrest 10 hours after the operation and could not be
resuscitated. Autopsy showed dehiscence of the
muscle bar of the homograft and acute left ventric-
ular outflow tract obstruction. An elderly man died
suddenly 1 week after the operation. Autopsy re-
vealed an acute type A aortic dissection with rupture
in the pericardial sac. Both patients had had chordal
replacement with ePTFE suture.
Ten patients had intraoperative complications:
Nine patients required a second pump run to correct
residual moderate MR (five as a result of systolic
anterior motion of the anterior leaflet), and one
* Gore-Tex suture, registered trade mark of W. L. Gore &
Associates, Inc., Flagstaff, Ariz.
Fig. 1. Technique of chordal replacement with ePTFE
suture.
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patient had an acute type A aortic dissection and
required replacement of the ascending aorta.
Thirty-nine patients had one or more postopera-
tive complications: reexploration of the mediasti-
num for hemorrhage in 19, myocardial infarction in
1, implantation of a permanent transvenous pace-
maker in 20, ischemic stroke in 1, hemorrhagic
stroke in 1, transient cerebral ischemic attacks in 3,
and severe hemolysis necessitating MVR in 1.
Patients were followed up from 6 to 156 months,
mean of 36 6 30 months (mean 6 standard devia-
tion). Twenty-one late deaths occurred: 14 cardiac
and 7 noncardiac. Of the cardiac deaths, 6 were due
to congestive heart failure, 4 were due to thrombo-
embolic complications, 1 was due to anticoagula-
tion-related hemorrhage, 2 were due to myocardial
infarction, and 1 was a sudden death. A Cox regres-
sion analysis identified age greater than 60 years as
the only independent variable associated with an
increased risk of late death. The actuarial survival
was 77% 6 5% at 10 years (Fig. 2).
After the third postoperative month, 72 patients
continued to receive warfarin because of persistent
atrial fibrillation, 140 were started on a regimen of
aspirin by their referring cardiologist, and 88 re-
ceived no anticoagulants or antiplatelet agents. In-
cluding the perioperative events, thromboembolic
complications occurred in 25 patients: 11 had tran-
sient ischemic attacks and 14 had strokes. Four
patients died of the stroke, four had various degrees
of permanent neurologic deficit, and six recov-
ered completely. Twelve of the 14 strokes occurred
during the first postoperative year. Transient isch-
emic attacks occurred at random. Atrial fibrillation,
the presence of an annuloplasty ring, the degree of
myxomatous changes in the MV leaflets, and the
presence of ePTFE chordae had no effect on the risk
of thromboembolism. Actually, no variable could be
Fig. 2. Actuarial survival after MV repair.
Table II. List of operations performed
All patients ePTFE No ePTFE
MV repair
Partial resection of posterior leaflet 260 (80) 116 (68) 150 (94)
Chordal replacement with ePTFE 165 (60) 165 (100) 0
Chordal shortening 63 (19) 44 (27) 19 (12)
Chordal transfer 12 (4) 2 (1) 10 (6)
Ring annuloplasty 279 (86) 142 (86) 137 (86)
Aortic valve surgery
Repair 10 (3) 8 (5) 2 (1)
Replacement 11 (4) 9 (5) 2 (1)
Replacement of ascending aorta 7 (2) 5 (3) 2 (1)
Tricuspid valve repair 9 (3) 6 (4) 3 (2)
Coronary artery bypass 40 (16) 16 (10) 24 (15)
Maze procedure for atrial fibrillation 7 (6) 5 (3) 2 (1)
Percentages are shown in parentheses. ePTFE, Expanded polytetrafluoroethylene; MV, mitral valve.
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identified as predictive of this complication. The
freedom from thromboembolic complications is
shown in Fig. 3. Two hemorrhagic complications
occurred in the same patient: cerebral bleeding 1
week after the operation and gastrointestinal bleed-
ing, which caused the patient’s death, 36 months
after the operation.
Infective endocarditis developed in only one pa-
tient, 13 months after aortic valve and MV repair,
and necessitated double valve replacement. The
freedom from infective endocarditis was 99% 6
0.5% at 10 years.
Reoperations on the MV were necessary in 10
patients. The indication for a second operation was
recurrent MR in eight patients and hemolysis in two. A
second MV repair was performed in four and MVR in
six patients. No operative deaths occurred among
these 10 patients. Eight of the 10 reoperations were
performed during the first postoperative year. Six of
these 10 patients had had chordal replacement with
ePTFE sutures. A Cox regression analysis identified
advanced myxomatous changes in the MV leaflets as
the only factor associated with increased risk of reop-
eration. Fig. 4 shows the freedom from MV reopera-
tion in all patients. For the subgroup of patients who
had chordal replacement with ePTFE, the freedom
from reoperation was 94% 6 2%, and for those
without chordal replacement it was 97% 6 1%.
In addition to 10 patients who required a second
MV operation, two others required coronary artery
bypass grafting, but nothing was done to their
normally functioning MV.
At the time of the most recent follow-up contact,
295 patients were alive and had their native MV; 195
(66%) were in New York Heart Association func-
tional class I, 78 (26%) were in class II, and 22 (7%)
in class III.
The most recent Doppler echocardiographic
study revealed mild or no MR in 269 (91%) patients,
moderate MR in 25 (8.4%), and severe MR in 2.
These two patients with severe MR were being
managed medically because of advanced age in one
(age 90 years) and complex disease in the other (the
patient in whom acute type A aortic dissection
developed during the operation). The freedom from
recurrent severe MR was 93% 6 2% at 10 years.
The most recent electrocardiogram showed sinus
rhythm in 223 patients, atrial fibrillation in 64, and
paced beats in 8.
Discussion
MR in patients with myxomatous disease of the
MV is often due to prolapse of the middle scallop of
the posterior leaflet.13 Isolated prolapse of the pos-
terior leaflet was found in 52% of our patients.
Repair of prolapse of the middle scallop is relatively
simple and usually can be accomplished by resection
of the prolapsing segment.14 We15 have observed
that resections larger than 1.5 cm with plication in a
single point impairs contractility of the posterior
wall of the left ventricle. When more than 1.5 cm of
posterior leaflet is resected, twice as much remain-
ing posterior leaflet should be detached from the
anulus and the sliding leaflet technique of Carpen-
tier used,16 because it prevents the problem of
posterior wall motion abnormality. In addition, pli-
cation of a large segment of the mitral anulus in
patients with a dominant circumflex artery may
cause kinking or obstruction of that artery with
consequent myocardial ischemia.17
Prolapse of the middle scallop of the posterior
leaflet increases the stresses in the central area of
the anterior leaflet.18, 19 We believe that longstand-
ing prolapse of the middle scallop of the posterior
leaflet may cause prolapse of the central portion of
Fig. 3. Freedom from thromboembolic complications.
Fig. 4. Freedom from MV reoperation.
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the anterior leaflet. This is probably the mechanism
of bileaflet prolapse in patients with mild myxoma-
tous changes of the valve. Bileaflet prolapse was
present in 30% of our patients. The remaining 18%
of our patients had isolated prolapse of the anterior
leaflet, which was due to elongation or rupture of
chordae tendineae. Chordal replacement with
ePTFE sutures has allowed us to repair the MV in
approximately 90% of the patients with anterior or
bileaflet prolapse. Other surgeons have reported
similar proportions of MV repair without the use of
ePTFE sutures.14, 17 Two techniques frequently used
to correct prolapse of the anterior leaflet are
chordal shortening for an elongated chorda14 and
chordal transfer for an elongated or ruptured chor-
da.17 Chordal shortening has been reported to be
associated with a higher failure rate than chordal
transfer.20 Smedira and associates20 reported a
5-year freedom from reoperation of 96% after
chordal transfer and of 74% after chordal shorten-
ing. Salati and colleagues17 reported on the midterm
results of chordal transfer to correct MR caused by
prolapse of the anterior leaflet, and the freedom
from reoperation was 88% at 5 years. The freedom
from recurrent severe MR was 93% at 10 years in
our patients. Although other factors may have pre-
vented recurrent MR in our patients, we believe that
the liberal use of multiple ePTFE sutures to replace
elongated and ruptured chordae tendineae and also
to reinforce flimsy chordae played an important role
in this successful late outcome. None of our failures
was due to the ePTFE chordae, but they may have
caused elongation of adjacent native chordae be-
cause of increased stress if the ePTFE chordae were
not the same length as the native chordae.18, 19
The ePTFE chordae become completely covered
by a fibrous sheath after the first year of implanta-
tion in human beings.10, 21 Examination of explanted
ePTFE chordae reveals that they remain pliable and
the fibrous sheath is covered by a single layer of
endothelial cells.21
The surgical pathology of myxomatous mitral
leaflets varies widely from minimal interchordal
hooding and increased leaflet area to extremely
voluminous leaflets that contain large aneurysms.
The leaflets are often opaque and thickened, but not
always in a uniform fashion; the lateral half of the
MV may appear entirely normal while the medial
half is grossly abnormal. We have observed that the
medial half of the MV frequently has more ad-
vanced myxomatous changes than its lateral half.
The chordae tendineae can be thin and elongated,
but sometimes thickened or even fused and calci-
fied. The mitral anulus is always dilated in patients
with myxomatous disease of the MV. The posterior
mitral anulus may become segmentally or entirely
calcified. This calcification may extend into the
posterior wall of the left ventricle, making removal
of that segment of the leaflet hazardous. MV repair
is usually feasible in patients with advanced myxo-
matous disease and even with calcification of the
mitral anulus,22, 23 but the probability of failure of
the repair is higher in these patients than in those
with more localized disease. Although the long-term
results of MV repair are better than those of MVR,
we have found that MVR with preservation of
chordae tendineae gives very satisfactory long-term
results in these patients.24 However, it is associated
with higher rates of valve-related complications.
In conclusion, MV repair is feasible in most
patients with MR resulting from myxomatous dis-
ease and is associated with a relatively low rate of
valve-related complications. Chordal replacement
with ePTFE sutures is a durable operative proce-
dure and it does not increase the risk of valve-
related complications. Patients with advanced myx-
omatous changes in both leaflets have an increased
risk of reoperation because of MV failure.
R E F E R E N C E S
1. Levy D, Savage D. Prevalence and clinical features of mitral
valve prolapse. Am Heart J 1987;113:1281-90.
2. Nishimura RA, McGoon MD, Shub C, et al. Echocardio-
graphically documented mitral valve prolapse: long-term
follow-up of 237 patients. N Engl J Med 1985;313:1305-9.
3. Olson LJ, Subramanian R, Ackermann DM, Orszulak TA,
Edwards WD. Surgical pathology of the mitral valve: a study
of 712 cases spanning over 21 years. Mayo Clin Proc 1987;
62:22-34.
4. David TE, Armstrong S, Sun Z, Daniel L. Late results of
mitral valve repair for mitral regurgitation due to degenera-
tive disease. Ann Thorac Surg 1993;56:7-14.
5. Cohn LH, Couper GS, Aranki SF, Rizzo RJ, Kinchla NM,
Collins JJ Jr. Long-term results of mitral valve reconstruction
for regurgitation of the myxomatous mitral valve. J Thorac
Cardiovasc Surg 1994;107:143-50.
6. Deloche A, Jebara VA, Relland JYM, et al. Valve repair with
Carpentier techniques: the second decade. J Thorac Cardio-
vasc Surg 1990;99:990-1002.
7. David TE, Uden DE, Strauss HD. The importance of the
mitral apparatus in left ventricular function after correction
of mitral regurgitation. Circulation 1983;68(Suppl):II76-82.
8. Yacoub M, Halim M, Radley-Smith R, et al. Surgical treat-
ment of mitral regurgitation caused by floppy valves: repair
versus replacement. Circulation 1981;64(Suppl):II211-6.
9. Ling LH, Enriques-Sarano M, Seward JB, et al. Clinical
outcome of mitral regurgitation due to flail leaflet. N Engl
J Med 1996;335:1417-23.
10. Vetter HO, Burack JH, Factor SM, Macaluso F, Frater
The Journal of Thoracic and
Cardiovascular Surgery
June 1998
1 2 8 4 David et al.
RWM. Replacement of chordae tendineae of the mitral valve
using the new expanded PTFE suture in sheep. In: Bodnar E,
Yacoub M, editors. Biologic bioprosthetic valves. New York:
Yorke Medical Books; 1986. p. 772-84.
11. David TE, Bos J, Rakowski H. Mitral valve repair by
replacement of chordae tendineae with polytetrafluoroethyl-
ene sutures. J Thorac Cardiovasc Surg 1991;101:495-501.
12. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller
DC, Weisel RD. Guidelines for reporting morbidity and
mortality after cardiac valvular operations. Ann Thorac Surg
1996;62:932-5.
13. Ranganathan N, Lam JHC, Wigle ED, Silver MD. Morphol-
ogy of the human mitral valve. II. The valve leaflets. Circu-
lation 1970;41:459-66.
14. Carpentier A. Cardiac valve surgery: the “French correc-
tion.” J Thorac Cardiovasc Surg 1983;86:323-37.
15. David TE, Komeda M, Pollick C, Burns RJ. Mitral valve
annuloplasty: the effect in left ventricular function after
correction of mitral regurgitation. Ann Thorac Surg 1989;47:
524-8.
16. Jebara VA, Mihaileanu S, Acar C, et al. Left ventricular
outflow tract obstruction after mitral valve repair: results of
the sliding leaflet technique. Circulation 1993;88(Suppl):
II30-4.
17. Salati M, Moriggia S, Scrofani R, Santoli C. Chordal trans-
position for anterior mitral prolapse: early and long-term
results. Eur J Cardiothorac Surg 1997;11:268-73.
18. Kunzelman KS, Cochran RP, Chuong C, et al. Finite element
analysis of the mitral valve. J Heart Valve Dis 1993;2:326-40.
19. Reimink MS, Kunzelman KS, Cochran RP. The effect of
chordal replacement suture length on function and stresses in
repaired mitral valves: a finite element analysis. J Heart
Valve Dis 1996;5:365-75.
20. Smedira NG, Selman R, Cosgrove DM, et al. Repair of
anterior leaflet prolapse: chordal transfer is superior to
chordal shortening. J Thorac Cardiovasc Surg 1996;112:287-
92.
21. Zussa C, editor. Artificial chordae in mitral valve surgery.
Austin [TX]: RG Landes Company; 1994. p. 75-112.
22. David TE, Feindel CM, Armstrong S, Sun Z. Reconstruction
of the mitral anulus: a ten-year experience. J Thorac Cardio-
vasc Surg 1995;110:132-42.
23. Carpentier AF, Pellerin M, Fuzellier JF, Relland JYM.
Extensive calcification of the mitral valve anulus: pathology
and surgical management. J Thorac Cardiovasc Surg 1996;
111:718-30.
24. David TE. Left ventricular function after mitral valve sur-
gery. J Heart Valve Dis 1995;4(Suppl):II175-80.
Discussion
Dr. Lawrence H. Cohn (Boston, Mass.). This presenta-
tion validates for me that MV repair with ePTFE, partic-
ularly with anterior leaflet and chordal replacement, is the
technique of choice. I think this is a much more repro-
ducible technique, it is much less traumatic, and it is much
easier to do. Reproducibility and simplicity are of primary
importance in MV repair. Dr. David, you are to be
congratulated for validating this in this excellent series.
We began using this technique routinely about 3 years
ago. We have a much smaller series, about 40 patients
whom we have followed up over a period of time, and
none of these patients has had any recurrence of MR or
any incidence of structural valve degeneration. Although
ours is a much smaller series, I think it helps to validate
your point.
I have a few questions related to your data and this
technique. First, you mentioned that you use annuloplasty
rings in 75% of the patients. Was the incidence of
recurrent MR, either acutely or chronically, higher in the
25% of patients that did not get an annuloplasty ring?
You also pointed out also that your incidence of heart
block was almost 6% in MV repair. That is a little bit
higher than I have seen, and I wondered if you could
discuss the reason for this higher incidence.
You also used ePTFE chordae for posterior leaflet
repair in a number of patients. In what circumstances
might you use a PTFE chorda for posterior leaflet repair
when usually resection is all that would be needed?
I congratulate you on describing to us the difficult part
of adjusting the length of the ePTFE chordae. In my
experience as well, making them too short is the trickiest
part of this technique.
Dr. David. Thank you, Dr. Cohn. I am glad that I
convinced you to start using ePTFE as well.
We compared patients with and without annuloplasty
rings by univariate and multivariate analysis as a predictor
for failure of MV repair, and it was not a predictor.
However, that when we resect the posterior leaflet, we do
reinforce the anulus with a pledget-supported suture when
plicating a single area. We do less and less plication of a
single area since I learned, with Dr. Carpentier, about his
sliding plasty. I believe that it not only decreased the risk of
systolic anterior motion, but also improved systolic function
in the operating room. Extensive plication in a single area
invariably is followed by an akinetic segment in the posterior
wall. Carpentier’s sliding plasty prevents that.
I agree that the incidence of heart block in this series is
a bit higher than reported before, at 5.4%, but I do not
know the reason. Perhaps the sutures holding the ring in
the medial fibrous trigone may have penetrated the bun-
dle. Interesting, one half of all patients who had a
pacemaker were in sinus rhythm when they came back for
the first follow-up visit 2 months postoperatively, indicat-
ing that we were overly aggressive in implanting pacemak-
ers, mostly because of pressure to discharge patients
prematurely. This is particularly true after the maze
procedure. These patients frequently do not have an
intact sinus mechanism and they might require atrial
pacing for a week or 10 days. The pressure to discharge
them after 4 or 5 days is so great that we may have to start
sending them home with a temporary pacer and check on
them daily by telephone.
The cases of posterior leaflet repair that necessitated
PTFE are those in which just about the entire posterior
leaflet was flail. I normally resect the midportion of the
scallop. I am reluctant to resect the commissural area
unless the patient had endocarditis at that site, in which
case I do a sliding plasty. Most of the posterior leaflets
that had PTFE chorda had it placed mostly in the
commissural areas.
Dr. Norberto G. De Vega (Malaga, Spain). I want to
comment about the use of rings. We very seldom use a
ring when we repair degenerative MVs. Using a ring is like
paying a tax for doing a mitral repair. And I continue to
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encounter surgeons who do not use rings, Professor
Yacoub, for one. It was very nice to hear from you that
you do not always use rings and that the long-term result
of your operations is not related to the use of rings.
My question was whether there was any difference in
the long-term result, and you have already said no. My
message is that probably too many rings are used in MV
repairs.
Dr. David. I do not know what happens first, the
annular dilatation or the chordal elongation. Patients who
have advanced myxomatous disease may have a dilated
fibrous skeleton, that is, the anulus dilates and, as it
dilates, it increases the wall tension on the leaflets and the
leaflets begin to stretch.
I used an annuloplasty ring in all my patients with
obvious myxomatous change in the leaflets. Those who did
not have a ring largely had what Professor Carpentier
refers to as fibroelastic deficiency. My pathologists claim
that there is no pathologic substrate for this disease. We
all know what fibroelastic deficiency is: If the leaflet is
thin, flimsy, extremely attenuated, we call this fibroelastic
deficiency. Those patients frequently have a normal mitral
anulus. I agree with you that those patients do not need an
annuloplasty ring.
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